Home Cart Sign in  
Chemical Structure| 522664-63-7 Chemical Structure| 522664-63-7

Structure of Ibodutant
CAS No.: 522664-63-7

Chemical Structure| 522664-63-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

MEN 15596 is a potent and selective tachykinin NK2 receptor antagonist with a pKi of 10.1.

Synonyms: MEN 15596

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Ibodutant

CAS No. :522664-63-7
Formula : C37H48N4O4S
M.W : 644.87
SMILES Code : O=C(C1=CC2=CC=C(C)C=C2S1)NC3(C(N[C@H](CC4=CC=CC=C4)C(NCC5CCN(CC6CCOCC6)CC5)=O)=O)CCCC3
Synonyms :
MEN 15596
MDL No. :MFCD14635358

Safety of Ibodutant

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01303224 Irritable Bowel Syndrome With ... More >>Diarrhea Less << Phase 2 Completed - -
NCT02107196 Irritable Bowel Syndrome With ... More >>Diarrhea Less << Phase 3 Completed - -
NCT01303224 - Completed - -
NCT02107196 - Completed - -
NCT02320318 Irritable Bowel Syndrome With ... More >>Diarrhea Less << Phase 3 Withdrawn December 2016 Korea, Republic of ... More >> Busan, Korea, Republic of, 602739 Daegu, Korea, Republic of, 705718 Gangwon-do, Korea, Republic of, 200704 Gyeonggi-do, Korea, Republic of, 463712 Gyeonggi-do, Korea, Republic of, 471701 Seoul, Korea, Republic of, 110744 Seoul, Korea, Republic of, 137701 Seoul, Korea, Republic of, 138736 Singapore Singapore, Singapore, 258500 Singapore, Singapore, 308433 Singapore, Singapore, 529889 Taiwan Kaohsiung, Taiwan, 807 Kaohsiung, Taiwan, 83301 Taichung, Taiwan, 40201 Tainan, Taiwan, 704 Taipei City, Taiwan, 10002 Taipei City, Taiwan, 11217 Taipei, Taiwan, 104 Taoyuan, Taiwan, 333 Yunlin, Taiwan, 640 Less <<
NCT02120027 - Terminated(Because of negative... More >> results of the sister study NAK-06 and the low overall response rate at week 24.) Less << - -
NCT00761007 Irritable Bowel Syndrome Phase 2 Completed - Denmark ... More >> Center for Clinical and Basic Research (CCBR) Ballerup, Denmark Germany emovis GmbH Berlin, Germany Latvia Digestive Diseases Center "Gastro" Riga, Latvia Russian Federation Federal State Institution "Outpatient clinic #3" of President's Management Department of the Russian Federation Moscow, Russian Federation Ukraine Academy of Medical Science of Ukraine Dnipropetrovsk, Ukraine United Kingdom Synexus Midlands Clinical Research Centre Birmingham, United Kingdom Less <<
NCT00761007 - Completed - -
NCT02120027 Irritable Bowel Syndrome With ... More >>Diarrhea Less << Phase 3 Terminated(Because of negative... More >> results of the sister study NAK-06 and the low overall response rate at week 24.) Less << - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.55mL

0.31mL

0.16mL

7.75mL

1.55mL

0.78mL

15.51mL

3.10mL

1.55mL

 

Historical Records

Categories